A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Krystal Biotech KRYS reported first-quarter 2025 earnings ... is currently developing a décolleté-specific photo numeric scale for advanced clinical development of KB301. This subsidiary expects ...

Krystal Biotech KRYS reported first-quarter 2025 earnings per share (EPS) of $1.20, which missed the Zacks Consensus Estimate ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2025 and provided a business ...

PITTSBURGH, May 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS ... is currently developing a décolleté-specific photo numeric scale for advanced clinical development of KB301.

The lustrous, metallic allure of gold has long fueled intrigue and in recent months its market fortunes have also reflected ...

HHS Secretary Robert F. Kennedy Jr. said the agency is planning to study what causes autism and release results in September. Experts question how realistic this goal is.

Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...

Immunologist Jacob Glanville came across media of a man who had injected himself hundreds of times with the venom of some of ...

How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs. As pressures on ...

PHILADELPHIA (AP) — Barstool Sports founder Dave Portnoy said he would send two customers to tour a former Nazi concentration ...